Article Versions Notes

Pinheiro MM, Pinheiro FMM, Di Serio BF, Padilla N, Nwosu BU, Della-Morte D, Ricordi C, Infante M. Combined Use of Vitamin D and DPP-4 Inhibitors as a Potential Adjuvant Treatment Strategy to Enhance the Efficacy of Novel Beta-Cell Replacement Therapies for Type 1 Diabetes. Medical Sciences. 2025; 13(3):141. https://doi.org/10.3390/medsci13030141

Pinheiro, Marcelo Maia, Felipe Moura Maia Pinheiro, Bruna Fioravante Di Serio, Nathalia Padilla, Benjamin Udoka Nwosu, David Della-Morte, Camillo Ricordi, and Marco Infante. 2025. "Combined Use of Vitamin D and DPP-4 Inhibitors as a Potential Adjuvant Treatment Strategy to Enhance the Efficacy of Novel Beta-Cell Replacement Therapies for Type 1 Diabetes" Medical Sciences 13, no. 3: 141. https://doi.org/10.3390/medsci13030141

Pinheiro, M. M., Pinheiro, F. M. M., Di Serio, B. F., Padilla, N., Nwosu, B. U., Della-Morte, D., Ricordi, C., & Infante, M. (2025). Combined Use of Vitamin D and DPP-4 Inhibitors as a Potential Adjuvant Treatment Strategy to Enhance the Efficacy of Novel Beta-Cell Replacement Therapies for Type 1 Diabetes. Medical Sciences, 13(3), 141. https://doi.org/10.3390/medsci13030141